Valuation: ResMed, Inc.

Market Cap 30.57B 26.44B 24.69B 22.65B 42.61B 2,910B 43.29B 290B 114B 1,458B 115B 112B 4,821B P/E 2026
18.7x
P/E 2027 * 18.4x
Enterprise Value 29.73B 25.71B 24.01B 22.03B 41.43B 2,829B 42.09B 282B 111B 1,418B 112B 109B 4,688B EV / Sales 2026
4.98x
EV / Sales 2027 * 5.09x
Free-Float
37.81%
Yield 2026 *
1.15%
Yield 2027 * 1.26%
1 day-5.06%
1 week+0.46%
Current month+0.46%
1 month-3.55%
3 months+2.44%
6 months-21.97%
Current year-12.01%
1 week 202
Extreme 202
226.12
1 month 190.21
Extreme 190.21
226.12
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
5/8/26 Sell

Founder

-8,000 0.0055%
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
9/2/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-5.06%+0.46%-24.35%+13.54% 30.57B
+2.41%+3.43%+30.62%+7.65% 220B
+2.39%+5.02%+3.16%-19.90% 144B
+1.36%+7.21%-19.37%+22.50% 134B
+0.02%+5.52%-52.11%-2.80% 71.46B
+0.45%+4.24%+15.13%+12.37% 51.71B
+1.05%+7.19%-14.42%-19.02% 50.84B
+3.28%+5.49%+28.07%+15.38% 41.23B
+1.79%+7.83%+46.35%+40.43% 39.95B
+2.08%+5.51%+0.94%-5.05% 32.42B
Average +0.98%+5.04%+1.40%+6.51% 81.56B
Weighted average by Cap. +1.54%+5.00%+3.93%+4.66%

Financials

2026 2027 *
Net sales 5.65B 4.89B 4.56B 4.19B 7.88B 538B 8B 53.55B 21.02B 270B 21.22B 20.76B 891B 5.83B 5.04B 4.71B 4.32B 8.12B 555B 8.25B 55.22B 21.67B 278B 21.88B 21.4B 919B
Net income 1.55B 1.34B 1.25B 1.15B 2.16B 147B 2.19B 14.65B 5.75B 73.76B 5.81B 5.68B 244B 1.63B 1.41B 1.32B 1.21B 2.27B 155B 2.31B 15.44B 6.06B 77.69B 6.12B 5.98B 257B
Net Debt -845M -731M -682M -626M -1.18B -80.38B -1.2B -8B -3.14B -40.29B -3.17B -3.1B -133B -923M -799M -746M -684M -1.29B -87.88B -1.31B -8.75B -3.43B -44.05B -3.47B -3.39B -146B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
07/08/26 US$211.94 -5.06% 3,810,341
06/08/26 US$223.24 -0.35% 1,786,085
05/08/26 US$224.03 +0.40% 1,746,578
04/08/26 US$223.14 +3.69% 1,742,551
03/08/26 US$215.19 +2.00% 1,466,073
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
211.94USD
Average target price
247.87USD
Spread / Average Target
+16.95%

Quarterly revenue - Rate of surprise